FR2383919A1 - Determination de b-endorphine - Google Patents

Determination de b-endorphine

Info

Publication number
FR2383919A1
FR2383919A1 FR7806984A FR7806984A FR2383919A1 FR 2383919 A1 FR2383919 A1 FR 2383919A1 FR 7806984 A FR7806984 A FR 7806984A FR 7806984 A FR7806984 A FR 7806984A FR 2383919 A1 FR2383919 A1 FR 2383919A1
Authority
FR
France
Prior art keywords
determination
endorphine
antigen
endorphin
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7806984A
Other languages
English (en)
Other versions
FR2383919B1 (fr
Inventor
Cho Hao Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2383919A1 publication Critical patent/FR2383919A1/fr
Application granted granted Critical
Publication of FR2383919B1 publication Critical patent/FR2383919B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/675—Beta-endorphins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne notamment un nouvel antigène. Il s'agit d'un antigène comprenant de la beta -endorphine liée par covalence à une matière de support immunogène. Cet antigène est utile notamment dans la détermination de beta -endorphine.
FR7806984A 1977-03-14 1978-03-10 Determination de b-endorphine Granted FR2383919A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/777,262 US4096237A (en) 1977-03-14 1977-03-14 Immunoassay for β-endorphin

Publications (2)

Publication Number Publication Date
FR2383919A1 true FR2383919A1 (fr) 1978-10-13
FR2383919B1 FR2383919B1 (fr) 1980-04-04

Family

ID=25109754

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7806984A Granted FR2383919A1 (fr) 1977-03-14 1978-03-10 Determination de b-endorphine

Country Status (7)

Country Link
US (1) US4096237A (fr)
JP (1) JPS53113010A (fr)
CH (1) CH642457A5 (fr)
DE (1) DE2811003A1 (fr)
FR (1) FR2383919A1 (fr)
GB (3) GB1597563A (fr)
NL (1) NL7801956A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1605026A (en) * 1977-03-28 1981-12-16 Wellcome Found Radioreceptor opioid assay
US4219468A (en) * 1978-11-13 1980-08-26 Hoffmann-La Roche Inc. Tritiated β-endorphin
US4469631A (en) * 1980-03-10 1984-09-04 The Regents Of The University Of California Fusion peptides comprising an expressible bacterial gene and β-endorphin
US4590168A (en) * 1983-02-14 1986-05-20 The Children's Medical Center Corporation Protein immunoassaying and purification
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
EP1950223A3 (fr) * 1998-03-09 2009-05-13 Zealand Pharma A/S Conjugués peptides pharmacologiquement actifs dotés d'une tendance réduite à l'hydrolyse enzymatique

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2219973A1 (fr) * 1973-03-02 1974-09-27 Schering Ag
FR2228477A1 (fr) * 1973-05-07 1974-12-06 Univ Ohio State
FR2347050A1 (fr) * 1976-04-06 1977-11-04 Filipp Geza Agent anti-inflammatoire et procede pour le preparer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2219973A1 (fr) * 1973-03-02 1974-09-27 Schering Ag
FR2228477A1 (fr) * 1973-05-07 1974-12-06 Univ Ohio State
FR2347050A1 (fr) * 1976-04-06 1977-11-04 Filipp Geza Agent anti-inflammatoire et procede pour le preparer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NV2030/77 *

Also Published As

Publication number Publication date
GB1597563A (en) 1981-09-09
GB1597562A (en) 1981-09-09
JPS53113010A (en) 1978-10-03
US4096237A (en) 1978-06-20
DE2811003A1 (de) 1978-09-28
CH642457A5 (de) 1984-04-13
FR2383919B1 (fr) 1980-04-04
GB1597561A (en) 1981-09-09
NL7801956A (nl) 1978-09-18

Similar Documents

Publication Publication Date Title
BG30474A3 (en) Method for obtaining of 6- propyl- 8- methoxymethyl- or- methylmercaptomethylergolin and simular compounds
FR2421874A1 (fr) Carboxyalkylacylamino-acides utiles comme agents hypotenseurs
FR2371449A1 (fr) Acide 1-carba-2-penem-3-carboxylique
FR2333244A1 (fr) Determination serologique de la presence d'anticorps anti-neisseria gonorrhoeae
FR2384262A1 (fr) Procede de determination immunologique
DE59307354D1 (de) Bestimmung von peptidmotiven auf mhc-molekülen
FR2375218A1 (fr) 2-imidazoline-5-ones a substitution chirale
FR2361328A1 (fr) Nouvelles benzophenones utiles notamment a la preparation d'oximes et d'hydrazones
FR2383919A1 (fr) Determination de b-endorphine
BG27905A3 (en) Method of obtaining of phospinous acids
FR2405238A1 (fr) Carbonates de triallyle monomeres
FR2390537A1 (fr) Melanges d'azureurs optiques derivant du stilbene
ATE117989T1 (de) Prostaglandinanaloge enthaltende lipidemulsion.
NL7711753A (nl) Werkwijze voor de bereiding van fluorescerende materialen.
DK165364C (da) Fedtsyreestere, kosmetisk middel indeholdende disse og fremgangsmaade til fremstilling af saadanne estere
FR2392958A1 (fr) Nouveaux amino-acides fluores utiles comme medicament
DE68916850D1 (de) Antikoagulierende Peptid-Alkohole.
FR2375200A1 (fr) Preparation de perfluoroalkylsulfonates de tetraethylammonium
FR2389639A1 (fr)
FR2381746A1 (fr) Nouveaux derives encephaliniques a la methionine
FR2410299A1 (fr) Halogenhydrates de 4,7-dihydroxybenzimidazole utiles comme agent antivoile photographique
DK0536192T3 (da) Hidtil ukendt promotorregion
FR2366307A1 (fr) Antigene utilisable pour la preparation d'anticorps specifiques des cathecolamines
FR2355500A1 (fr) Composition antimicrobienne a base de 1-acyloxy-2-imidazolyl-1-phenylethanes
KR840005146A (ko) N-(2-메톡시에틸)-노르옥시모르폰의 제조방법

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse